{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:38:00Z","timestamp":1760060280231,"version":"build-2065373602"},"reference-count":22,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Introduction: In healthcare centers with limited resources, or for patients who prefer to make continuous changes in their treatment themselves and do not want to rely solely on technology, intermittent glucose monitoring (isCGM) with an insulin pump is a viable option that warrants further study. Material and methods: prospective single-center study that collected data at 3 months and after isCGM implantation in pediatric patients with Type 1 diabetes, categorized according to their insulin regimen. Results: We found statistically significant differences in the time in range (TIR) between 70 and 180 mg\/dl at 3 months after using the sensor (p = 0.017), although these differences were not maintained at 1 year (p = 0.064). When stricter TIRs (70\u2013140 mg\/dl) were analyzed, statistically significant differences were observed at 3 months (p = 0.01) and at 1 year (p = 0.018) in favor of patients using CSII. While 75% of the patients in the CSII group had good control with HbA1c &lt; 7% after one year of sensor use, only 34.6% in the MDI group achieved these values. However, the CSII group presented a higher coefficient of variation (62.31% at 3 months and 43.08% at 1 year) (p = 0.02), and a higher number of hypoglycemic episodes (7.38% and 7.32%, respectively) (p = 0.016). The CSII group also had a higher number of capillary blood glucose measurements at the beginning of the study (8.32\/day) (p = 0.249), but this number became similar between both groups after one year. Conclusions: We found statistically significant differences in favor of CSII over MDI in terms of metabolic control after one year of isCGM use. However, the TIR values were still below the range considered to be indicative of good control. These findings lead us to question whether CSII should be initially considered in specific cases where HCL is not possible, or if it would be more effective to wait until the patient is ready, or the necessary resources are available to start directly CSII integrated in a closed loop system.<\/jats:p>","DOI":"10.3390\/diseases13080254","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T08:10:32Z","timestamp":1754899832000},"page":"254","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differences in Metabolic Control Between Different Insulin Use Patterns in Pediatric Patients with Type 1 Diabetes Through Intermittent Glucose Monitoring"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7270-4531","authenticated-orcid":false,"given":"Rocio","family":"Porcel-Chac\u00f3n","sequence":"first","affiliation":[{"name":"Universitary Costa del Sol Hospital A-7, Km 187, 29603 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4248-2645","authenticated-orcid":false,"given":"Leopoldo","family":"Tapia-Ceballos","sequence":"additional","affiliation":[{"name":"Regional University Hospital of Malaga, Avda Arroyo de los Angeles, s\/n, 29009 M\u00e1laga, Spain"},{"name":"Institute of Biomedicine of Malaga (IBIMA), C. Severo Ochoa, 35, Campanillas, 29590 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-0886","authenticated-orcid":false,"given":"Ana-Belen","family":"Ariza-Jimenez","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology Service, Reina Sofia University Hospital, Avda. Menendez Pidal, s\/n, 14004 Cordoba, Spain"},{"name":"Growth Study Group, Pediatric Endocrinology and Nutrition, Maimonides Institute of Biomedical Research of Cordoba, Av. Menendez Pidal, s\/n, 14004 Cordoba, Spain"},{"name":"Department of Pediatrics, University of Cordoba, Avda Menendez Pidal, 7, 14004 Cordoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-4212","authenticated-orcid":false,"given":"Ana","family":"G\u00f3mez-Perea","sequence":"additional","affiliation":[{"name":"Regional University Hospital of Malaga, Avda Arroyo de los Angeles, s\/n, 29009 M\u00e1laga, Spain"},{"name":"Institute of Biomedicine of Malaga (IBIMA), C. Severo Ochoa, 35, Campanillas, 29590 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Manuel","family":"Jim\u00e9nez-Hinojosa","sequence":"additional","affiliation":[{"name":"Regional University Hospital of Malaga, Avda Arroyo de los Angeles, s\/n, 29009 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-9139","authenticated-orcid":false,"given":"Juan-Pedro","family":"L\u00f3pez-Siguero","sequence":"additional","affiliation":[{"name":"Regional University Hospital of Malaga, Avda Arroyo de los Angeles, s\/n, 29009 M\u00e1laga, Spain"},{"name":"Institute of Biomedicine of Malaga (IBIMA), C. Severo Ochoa, 35, Campanillas, 29590 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-7253","authenticated-orcid":false,"given":"Isabel","family":"Leiva-Gea","sequence":"additional","affiliation":[{"name":"Regional University Hospital of Malaga, Avda Arroyo de los Angeles, s\/n, 29009 M\u00e1laga, Spain"},{"name":"Institute of Biomedicine of Malaga (IBIMA), C. Severo Ochoa, 35, Campanillas, 29590 M\u00e1laga, Spain"},{"name":"Department of Biomedicine and Dentistry, Faculty of Biomedical Sciences and Sports, Universidad Europea de Andaluc\u00eda, 29010 M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Diabetes Association (2019). 13. Children and Adolescents: Standards of Medical Care in Diabetes-2019. Diabetes Care, 42, S148\u2013S164.","DOI":"10.2337\/dc19-S013"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: Overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International Consensus on Use of Continuous Glucose Monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1399-5448.2009.00596.x","article-title":"Target setting in intensive insulin management is associated with metabolic control: The Hvidoere childhood diabetes study group centre differences study 2005","volume":"11","author":"Swift","year":"2010","journal-title":"Pediatr. Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00125-008-0974-3","article-title":"Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: Systematic review and meta-analysis","volume":"51","author":"Jeitler","year":"2008","journal-title":"Diabetologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1210\/jc.2008-1415","article-title":"Clinical review: Hypoglycemia with intensive insulin therapy: A systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections","volume":"94","author":"Fatourechi","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.324.7339.705","article-title":"Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: Meta-analysis of randomised controlled trials","volume":"324","author":"Pickup","year":"2002","journal-title":"BMJ"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1464-5491.2007.02311.x","article-title":"Comparison of continuous subcutaneous insulin infusion (CSII) and multiple daily injections (MDI) in paediatric Type 1 diabetes: A multicentre matched-pair cohort analysis over 3 years","volume":"25","author":"Jakisch","year":"2008","journal-title":"Diabet. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19","author":"DiMeglio","year":"2018","journal-title":"Pediatric. Diabetes"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations from the International Consensus on Time in Range","volume":"42","author":"Barttelino","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s13300-019-00720-0","article-title":"The Impact of Flash Glucose Monitoring on Glycaemic Control as Measured by HbA1c: A Meta-analysis of Clinical Trials and Real-World Observational Studies","volume":"11","author":"Evans","year":"2020","journal-title":"Diabetes Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.1089\/dia.2018.0091","article-title":"The Hybrid Closed-Loop System: Evolution and Practical Applications","volume":"20","author":"Weaver","year":"2018","journal-title":"Diabetes Technol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.2337\/dc20-0112","article-title":"Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial","volume":"43","author":"Parkin","year":"2020","journal-title":"Diabetes Care"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diabres.2019.05.015","article-title":"Comparison of flash glucose monitoring with real time continuous glucose monitoring in children and adolescents with type 1 diabetes treated with continuous subcutaneous insulin infusion","volume":"152","author":"Massa","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"11795514221128495","DOI":"10.1177\/11795514221128495","article-title":"The Effectiveness of Insulin Pump Therapy Versus Multiple Daily Injections in Children With Type 1 Diabetes Mellitus in a Specialized Center in Riyadh","volume":"15","author":"Babiker","year":"2022","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1007\/s12325-022-02058-9","article-title":"Cost-Effectiveness of Hybrid Closed Loop Insulin Pumps Versus Multiple Daily Injections Plus Intermittently Scanned Glucose Monitoring in People With Type 1 Diabetes in The Netherlands","volume":"39","author":"Roze","year":"2022","journal-title":"Adv Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa2004736","article-title":"A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes","volume":"383","author":"Breton","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s40200-025-01569-w","article-title":"Evaluation of glycemia risk index and continuous glucose monitoring-derived metrics in type 1 diabetes: A real-world observational study","volume":"24","year":"2025","journal-title":"J. Diabetes Metab. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102265","DOI":"10.1016\/j.dsx.2021.102265","article-title":"Effectiveness of the freestyle libre 2 flash glucose monitoring system on diabetes-self-management practices and glycemic parameters among patients with type 1 diabetes using insulin pump","volume":"15","author":"Robert","year":"2021","journal-title":"Diabetes Metab. Syndr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1089\/dia.2020.0031","article-title":"Time In Range in Children with Type 1 Diabetes Using Treatment Strategies Based on Nonautomated Insulin Delivery Systems in the Real World","volume":"22","author":"Cherubini","year":"2020","journal-title":"Diabetes Technol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1111\/dom.15434","article-title":"Clinical features of type 1 diabetes in older adults and the impact of intermittently scanned continuous glucose monitoring: An Association of British Clinical Diabetologists (ABCD) study","volume":"26","author":"Deshmukh","year":"2024","journal-title":"Diabetes Obes. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.numecd.2021.02.028","article-title":"Real-world outcomes with different technology modalities in type 1 diabetes","volume":"31","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/8\/254\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:27:04Z","timestamp":1760034424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/8\/254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["diseases13080254"],"URL":"https:\/\/doi.org\/10.3390\/diseases13080254","relation":{},"ISSN":["2079-9721"],"issn-type":[{"type":"electronic","value":"2079-9721"}],"subject":[],"published":{"date-parts":[[2025,8,9]]}}}